News

2022.08.08News Release

Maruho Launches the First Antibody Treatment Targeting Itch Associated with Atopic Dermatitis "Mitchga Subcutaneous Injection 60mg Syringes" in Japan

2022.05.23News Release

Maruho Launches Primary Axillary Hyperhidrosis Treatment "Rapifort Wipes 2.5%" in Japan

2022.04.29News Release

Incyte and Maruho Announce Strategic Alliance Agreement for Ruxolitinib Cream in Japan

2022.03.28News Release

Maruho Acquires Manufacturing and Marketing Approval in Japan for "Mitchga Subcutaneous Injection 60mg Syringes", a New Treatment Targeting Itch Associated with Atopic Dermatitis

2022.01.20News Release

Maruho Receives Manufacturing and Marketing Approval for Primary Axillary Hyperhidrosis Treatment "Rapifort Wipes 2.5%" in Japan